Target intelligence / Profile preview

Required for excision 1-B domain containing (REX1BD)

Target
REX1BD
Molecular classification
Other (uncharacterized protein; not classified as receptor, enzyme, transporter, ion channel, or transcription factor)
01

Overview

Required for excision 1-B domain containing (REX1BD) is a protein-coding gene in humans, sometimes also known as C19orf60. It encodes an uncharacterized protein with no confirmed molecular function or biological process annotation and does not belong to a well-established protein family such as enzymes, receptors, or ion channels. REX1BD is associated in the literature with certain forms of leprosy, but the nature and significance of this association are not well-defined. There are no experimentally confirmed drugs targeting this protein, and its biological function in health or disease remains unclear. Key points: No confirmed role as a therapeutic target, receptor, enzyme, transporter, or transcription factor. It is notable for its unknown function, with annotations stressing lack of experimental evidence for molecular function or biological process. It is encoded by a single-gene locus on human chromosome 19. There are no known interacting drugs, mechanisms of action, approved biomarkers, or safety concerns due to absence of validated biological activity data.

Other names
C19orf60FLJ20850FLJ30108
02

Biological functions

Unknown (no experimental evidence supporting a defined biological process or molecular function)
03

Disease associations

Other (borderline leprosy and indeterminate leprosy association reported, but causal/mechanistic link unclear)

Beyond the preview

Go deeper on Required for excision 1-B domain containing (REX1BD).

Explore the evidence, development activity, and competitive landscape with Gosset’s full data platform.

Drug pipeline

Full profile access

Explore the programs pursuing this target and their development progress.

  • Drug candidates
  • Developers
  • Development stage

Clinical trials

Full profile access

Follow the clinical studies evaluating therapies directed at this target.

  • Trial design
  • Status
  • Readouts

Competitive landscape

Full profile access

Compare approaches across drug candidates, modalities, and indications.

  • Programs
  • Modalities
  • Indications

Literature & evidence

Full profile access

Investigate the research and source evidence behind target biology and development.

  • Publications
  • Sources
  • Analysis

Patents

Full profile access

Explore patent activity around therapies and technologies addressing this target.

  • Patents
  • Assignees
  • Technologies

Research & analysis

Full profile access

Connect target biology, drug development, and emerging evidence in your research.

  • Biology
  • Development news
  • Analysis

Bring the full picture into focus.

See how Gosset can support your research on Required for excision 1-B domain containing (REX1BD).

Explore the full profile

Gosset Free

Get started with Gosset.

Enter your work email and we’ll be in touch with next steps.

Work email preferred.

Book a call